"WEDNESDAY, April 25 (HealthDay News) -- Higher doses of cholesterol-lowering statins may not be cost-effective for all heart patients, U.S. researchers find."
"In the study, a team from the University of Michigan Cardiovascular Center and the VA Ann Arbor Healthcare System performed a computer analysis of data from thousands of heart patients."
"They found that patients with a recent history of acute coronary syndrome -- either a heart attack or a hospital stay for chest pain -- get more than four additional quality-adjusted months of life from higher doses of statins."